Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Fomepizole is an inhibitor of alcohol dehydrogenase used as an antidote in confirmed or suspected methanol or ethylene glycol poisoning.
- Mechanism
- Curator reviewed
Antizol (fomepizole) is a competitive inhibitor of alcohol dehydrogenase. Alcohol dehydrogenase catalyzes the oxidation of ethanol to acetaldehyde. Alcohol dehydrogenase also catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites.
- Primary indication
- Antizol is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning, or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysisCurator reviewed · 2 structured indications
- Formula / weight
- C4H6N2 · 82.1038 g/mol (avg)
- First approval
- Canada, 2014 · United States, 2007
- Also known as
- 4-methylpyrazol · 4-methylpyrazole
- Brand names
- Antizol
Resolves to
Clinical / RWD
Structure
InChIKey
RIKMMFOAQPJVMX-UHFFFAOYSA-NSMILESCC1=CNN=C1What you can answer from here — as of September 23, 2026
4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Fomepizole, and which of those have an active Phase 3 trial?